233 related articles for article (PubMed ID: 18443114)
1. Mutational events in cefotaximase extended-spectrum beta-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance.
Novais A; Cantón R; Coque TM; Moya A; Baquero F; Galán JC
Antimicrob Agents Chemother; 2008 Jul; 52(7):2377-82. PubMed ID: 18443114
[TBL] [Abstract][Full Text] [Related]
2. In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?
Ripoll A; Baquero F; Novais A; Rodríguez-Domínguez MJ; Turrientes MC; Cantón R; Galán JC
Antimicrob Agents Chemother; 2011 Oct; 55(10):4530-6. PubMed ID: 21788458
[TBL] [Abstract][Full Text] [Related]
3. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX-M β-lactamases.
Patel MP; Fryszczyn BG; Palzkill T
Antimicrob Agents Chemother; 2015 Nov; 59(11):6741-8. PubMed ID: 26282414
[TBL] [Abstract][Full Text] [Related]
5. Convergent in vivo and in vitro selection of ceftazidime resistance mutations at position 167 of CTX-M-3 beta-lactamase in hypermutable Escherichia coli strains.
Stepanova MN; Pimkin M; Nikulin AA; Kozyreva VK; Agapova ED; Edelstein MV
Antimicrob Agents Chemother; 2008 Apr; 52(4):1297-301. PubMed ID: 18212109
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of functionally distinct substitutions in β-lactamase variants shed light on the evolution of bacterial drug resistance.
Patel MP; Hu L; Brown CA; Sun Z; Adamski CJ; Stojanoski V; Sankaran B; Prasad BVV; Palzkill T
J Biol Chem; 2018 Nov; 293(46):17971-17984. PubMed ID: 30275013
[TBL] [Abstract][Full Text] [Related]
7. The Drug-Resistant Variant P167S Expands the Substrate Profile of CTX-M β-Lactamases for Oxyimino-Cephalosporin Antibiotics by Enlarging the Active Site upon Acylation.
Patel MP; Hu L; Stojanoski V; Sankaran B; Prasad BVV; Palzkill T
Biochemistry; 2017 Jul; 56(27):3443-3453. PubMed ID: 28613873
[TBL] [Abstract][Full Text] [Related]
8. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
Stürenburg E; Kühn A; Mack D; Laufs R
J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
[TBL] [Abstract][Full Text] [Related]
9. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly.
Bonnet R; Dutour C; Sampaio JL; Chanal C; Sirot D; Labia R; De Champs C; Sirot J
Antimicrob Agents Chemother; 2001 Aug; 45(8):2269-75. PubMed ID: 11451684
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of cefotaxime-resistant but ceftazidime-susceptible Enterobacterales and evaluation of the in vitro bactericidal activity of ceftazidime and cefepime.
Marchisio ML; Liebrenz KI; Méndez ELA; Di Conza JA
Braz J Microbiol; 2021 Dec; 52(4):1853-1863. PubMed ID: 34269999
[TBL] [Abstract][Full Text] [Related]
11. Antagonism between substitutions in β-lactamase explains a path not taken in the evolution of bacterial drug resistance.
Brown CA; Hu L; Sun Z; Patel MP; Singh S; Porter JR; Sankaran B; Prasad BVV; Bowman GR; Palzkill T
J Biol Chem; 2020 May; 295(21):7376-7390. PubMed ID: 32299911
[TBL] [Abstract][Full Text] [Related]
12. CTX-M-1- and CTX-M-15-type beta-lactamases in clinical Escherichia coli isolates recovered from food-producing animals in France.
Meunier D; Jouy E; Lazizzera C; Kobisch M; Madec JY
Int J Antimicrob Agents; 2006 Nov; 28(5):402-7. PubMed ID: 17027237
[TBL] [Abstract][Full Text] [Related]
13. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.
Cartelle M; del Mar Tomas M; Molina F; Moure R; Villanueva R; Bou G
Antimicrob Agents Chemother; 2004 Jun; 48(6):2308-13. PubMed ID: 15155242
[TBL] [Abstract][Full Text] [Related]
14. Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance.
Novais A; Comas I; Baquero F; Cantón R; Coque TM; Moya A; González-Candelas F; Galán JC
PLoS Pathog; 2010 Jan; 6(1):e1000735. PubMed ID: 20107608
[TBL] [Abstract][Full Text] [Related]
15. Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland.
Baraniak A; Fiett J; Hryniewicz W; Nordmann P; Gniadkowski M
J Antimicrob Chemother; 2002 Sep; 50(3):393-6. PubMed ID: 12205064
[TBL] [Abstract][Full Text] [Related]
16. CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like β-lactamases identified in an Escherichia coli clinical isolate.
Tian GB; Huang YM; Fang ZL; Qing Y; Zhang XF; Huang X
J Antimicrob Chemother; 2014 Aug; 69(8):2081-5. PubMed ID: 24777903
[TBL] [Abstract][Full Text] [Related]
17. Emergence and dominance of CTX-M-15 extended spectrum beta-lactamase among Escherichia coli isolates from children.
Réjiba S; Mercuri PS; Power P; Kechrid A
Microb Drug Resist; 2011 Jun; 17(2):135-40. PubMed ID: 21288137
[TBL] [Abstract][Full Text] [Related]
18. Selection of SHV extended-spectrum-beta-lactamase-dependent cefotaxime and ceftazidime resistance in Klebsiella pneumoniae requires a plasmid-borne blaSHV gene.
Hammond DS; Harris T; Bell J; Turnidge J; Giffard PM
Antimicrob Agents Chemother; 2008 Feb; 52(2):441-5. PubMed ID: 17999968
[TBL] [Abstract][Full Text] [Related]
19. Predictive analysis of ceftazidime hydrolysis in CTX-M-type beta-lactamase family members with a mutational substitution at position 167.
Kimura S; Ishii Y; Tateda K; Yamaguchi K
Int J Antimicrob Agents; 2007 Mar; 29(3):326-31. PubMed ID: 17258896
[TBL] [Abstract][Full Text] [Related]
20. Characterization of two new CTX-M-25-group extended-spectrum β-lactamase variants identified in Escherichia coli isolates from Israel.
Vervoort J; Baraniak A; Gazin M; Sabirova J; Lammens C; Kazma M; Grabowska A; Izdebski R; Carmeli Y; Kumar-Singh S; Gniadkowski M; Goossens H; Malhotra-Kumar S; ;
PLoS One; 2012; 7(9):e46329. PubMed ID: 23050014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
